Prokidney Corp. (PROK) — 10-Q Filings

10-Q Filings (6)

• ProKidney Narrows Q3 Loss, Cash Reserves Dwindle Amid R&D Spend — Nov 10, 2025 Risk: high
  PROKIDNEY CORP. reported a net loss of $16.469 million for the three months ended September 30, 2025, an improvement from a net loss of $17.910 million in the s
• ProKidney's Losses Widen Amid R&D Spend, Cash Drains — Aug 12, 2025 Risk: high
  PROKIDNEY CORP. reported a net loss attributable to Class A common stockholders of $16.552 million for the three months ended June 30, 2025, an increase from $1
• ProKidney Corp. Files 10-Q for Q1 2025 — May 12, 2025 Risk: medium
  ProKidney Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Social Capital Suvretta Holdings Corp. III, is focused on bi
• ProKidney Corp. Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  ProKidney Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly Social Capital Suvretta Holdings Corp. III, is involved in biolog
• ProKidney Corp. Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
  ProKidney Corp. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business operations. Key
• Prokaryotic Corp. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: medium
  PROKIDNEY CORP. (PROK) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Prokaryotic Corp. filed its 10-Q report for the period ending March 31, 202

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX